Advancing regulatory science for medical countermeasure development : workshop summary

Advancing regulatory science for medical countermeasure development : workshop summary /

Show other versions (1)

Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community a...

Full description

Saved in:
Bibliographic Details
Online Access: http://www.ncbi.nlm.nih.gov/books/NBK83207/
Full text
Corporate Authors: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events
Other Authors: Wizemann, Theresa M., Altevogt, Bruce M., Claiborne, Anne B.
Format: Electronic eBook
Language:English
Published: Washington, D.C. : Natlional Academies Press, 2011
Subjects:
United States. > Food and Drug Administration.
Disaster Medicine.
United States.
Congress.

Internet

http://www.ncbi.nlm.nih.gov/books/NBK83207/
Full text

Similar Items